![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Amidst Controversy, FDA Issues EUA Allowing Anti-Malaria Drugs to Be Used to Treat COVID-19
Only time will tell if any of the assays, medical equipment or drugs the U.S....
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19
Johnson & Johnson announced the selection of a lead COVID-19 vaccine candidate from constructs it...
Chembio Announces Launch of DPP COVID-19 Serological Point-of-Care Test
Chembio Diagnostics, Inc. , a leading point-of-care diagnostic company focused on infectious diseases, announced the...
Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic...
Eli Lilly and Company announced an exclusive global licensing and research collaboration with Sitryx, a...
J&J Identifies Lead COVID-19 Vaccine Candidate, Commits to Supply 1 Billion Vaccines Worldwide
Johnson & Johnson is moving forward with a vaccine candidate for COVID-19. The healthcare giant...
Destroying DNA to Save the Genome – Study Offers New Insights into Sepsis and...
Sepsis is a life-threatening condition that kills millions annually; it is poorly understood and has...
C2 PHARMA Opens Government and Research Access to Safety Stock of DIGOXIN API for...
C2 PHARMA s.a.r.l. (C2P), a Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, is...
Leveraging synergies in pre-clinical biomedical R&D – pharmaceutical companies benefit from new innovation models
Introduction: As the complexity of pharmaceutical research and development increases constantly, its innovation productivity defined...
Univercells launches cell & gene therapy CMDO Exothera with GMP capabilities in 15,000m2 site...
Univercells has launched a contract development and manufacturing organization (CDMO), Exothera, to support cell and...
Coronavirus Drug Development Update from NanoViricides, Inc
NanoViricides, Inc. a leader in the development of highly effective antiviral therapies based on a...